SunTrust Robinson Humphrey analyst, Edward Nash, reiterated his Buy rating on shares of Viking Therapeutic (NASDAQ: VKTX) after the company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE